3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
2
Sarcoma
1
Plasma cell
1
Myeloid
1
Conditions
Sarcoma
9
Rhabdomyosarcoma
4
Rhabdoid Tumor
4
Osteosarcoma
4
Central Nervous System Neoplasms
4
Brain Neoplasms
4
Neuroectodermal Tumors, Primitive, Peripheral
3
Neuroblastoma
3
Medulloblastoma
3
Testicular Neoplasms
2
Testicular Germ Cell Tumor
2
Spinal Cord Neoplasms
2
Sarcoma, Ewing
2
Ovarian Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Kidney Neoplasms
2
Choroid Plexus Neoplasms
2
Carcinoma, Renal Cell
2
Astrocytoma
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Teratoma
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Retinoblastoma
1
Recurrence
1
Pinealoma
1
Ovarian Germ Cell Cancer
1
Optic Nerve Glioma
1
Interventions
Cyclophosphamide
17
pembrolizumab
12
Doxorubicin
10
fludarabine
7
Irinotecan
7
Blood Specimen Collection
7
Temozolomide
6
Gemcitabine
6
Etoposide
6
Radiotherapy
5
Ifosfamide
5
Carboplatin
5
Albumin-Bound Paclitaxel
5
tecogalan
4
cemiplimab
4
Vincristine
4
Trabectedin
4
Paclitaxel
4
Nivolumab
4
Filgrastim
4
Drug Therapy
4
Dexamethasone
4
Bevacizumab
4
pazopanib
3
olaparib
3
nilotinib
3
dostarlimab
3
aflibercept
3
Therapeutics
3
Taxes
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
etoposide phosphate
×
Sarcoma
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled